INSIGHTS ON UPSTREAM MANUFACTURING
-
Cell Insights By Umetrics® Studio
Cell Insights by Umetrics® Studio simplifies advanced data analytics for bioprocessing, offering hybrid modeling, virtual bioreactor simulations, and cell insights to streamline development, and support data-driven decisions.
-
Enhanced mAb Production With High-Intensity Perfusion CHO Medium
Reach new heights in mAb production with a high-intensity perfusion CHO medium designed to support consistently high product yield and quality in continuous perfusion cultures using CHO-K1 cells.
-
Depth Filters For The Clarification Of AAV
Explore study results demonstrating the ability of Sartoclear® depth filters to deliver high performance for AAV clarification, ensuring scalability, high recovery rates, and robust filtration.
-
How To Boost AAV Titer With Feed Supplementation In Both HEK293 And Sf-9 Platforms
Explore how optimizing post-transfection or post-infection feeding in HEK293 and Sf-9 cells significantly boosts AAV titers, enhancing production efficiency for gene therapy applications.
-
Epitope Base Editing CD45 In Hematopoietic Cells Enables Universal Blood Cancer Immune Therapy11/22/2024
Researchers developed base-edited CAR T cells and CD45-edited stem cells to create universal blood cancer immunotherapy, showcasing efficacy while minimizing toxicity using MaxCyte electroporation technology.
-
Unlocking The Potential Of Electroporation11/22/2024
Electroporation enables genetic research by introducing material into cells, advancing disease modeling, gene therapy, and ion channel studies. MaxCyte technology offers scalable, efficient solutions for high-throughput applications.
-
Electroporation Enables Efficient Antibody Discovery By Mammalian Display11/22/2024
Therapeutic antibody developers leverage mammalian display to identify promising candidates. Electroporation enables superior sequence diversity, enhanced library coverage, and streamlined workflows.
-
Efficient, Scalable Manufacturing Using A GMP-Compatible Electroporation Platform11/22/2024
Genome editing with virus-like particles (VLPs) shows promise for gene therapy. Using electroporation, researchers achieved high VLP yields, and genome editing, advancing therapeutic applications.
UPSTREAM MANUFACTURING SOLUTIONS
-
pPLUS® AAV-RC plasmids are optimized RepCap plasmids for high-yield AAV production in HEK293 cells, compatible with various serotypes and supporting efficient, reliable viral vector manufacturing.
-
FectoVIR®-LV is an animal-free transfection reagent for HEK-293 cells, optimizing lentiviral vector production through enhanced stability, and GMP development for regulated manufacturing processes.
-
The ExPERT Electroporation Platform accelerates cell therapy development with scalable, high-efficiency transfection, enabling seamless transitions from research to clinical manufacturing while supporting a wide range of cell types.
-
By streamlining timelines and reducing risks in downstream processes, Abzena’s solutions enhance efficiency, helping developers navigate the IND pathway more effectively and meet critical milestones with confidence.
-
Selecting the right medium to optimally match your cell line and process can be challenging. Our Cellvento®CHO media portfolio provides you with process and cell line specific cell culture media and feeds – so that you can find the most suitable product for your application.